The Department of Health and Social Care (DHSC) has today (18/11/2025) confirmed the following initial list of price concessions for November 2025:

Drug Pack size Price concession
Co-careldopa 12.5mg/50mg tablets 90 £5.97
Co-careldopa 25mg/100mg tablets 100 £8.26
Febuxostat 80mg tablets 28 £4.09
Fexofenadine 180mg tablets 30 £3.89
Ibandronic acid 150mg tablets 1 £18.40
Latanoprost 50micrograms/ml eye drops 2.5 £1.83
Mefenamic acid 500mg tablets 28 £28.01
Methenamine hippurate 1g tablets 60 £17.80
Olanzapine 2.5mg tablets 28 £1.84
Olanzapine 5mg tablets 28 £1.58
Tolterodine 1mg tablets 56 £1.55
Tolterodine 2mg tablets 56 £2.49
Trihexyphenidyl 5mg tablets 84 £124.00

There are no prices that rolled over from the previous month.

Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department. 

Notes  

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.  

Next Steps  

Pharmacies should continue to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on our website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, submit further price concession applications to DHSC. Any prices granted by DHSC, will only be agreed by Community Pharmacy England if they are supported by the reports received by our team. 

Please  subscribe to our mailing list to receive email updates of any price concessions. 

Further information on price  concessions and FAQs about the process  involved  can be found on our website (cpe.org.uk/priceconcessions 

The post November 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.